PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support

PeerCurrent

PcPeerCurrent

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Set your cadence Alerts Settings Help

Back to follows

Researcher

Maria Vittoria Cossu

ASST Fatebenefratelli Sacco

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials Reviews Guidelines

Latest

Everything in the corpus, newest first.

SEP 10, 2026 · JOURNAL ARTICLE

Long‐acting cabotegravir and rilpivirine in people with HIV and cancer: Virological eligibility and DDI considerations

British Journal of Clinical Pharmacology

Retrospective single-centre assessment of theoretical eligibility and drug-drug interactions; descriptive analysis without a comparator, control group, or clinical outcome measurement.

PreliminaryCristina Gervasoni Andrea Giacomelli Dario Cattaneo

Reported

Total PWH with cancer enrolled168

ART-experienced participants anal…154

Clinical conditions affecting ora…59/154 (38.3%)

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support